Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | TACR2 | P21452 | 3/20 | 0.44 |
| ▸ | GJB2 | P29033 | 2/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.42 |
| ▸ | CDC25B | P30305 | 3/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.41 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.41 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.41 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.41 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24378581 | 0.88 | GJB2 (0.50) | NT5ETACR2GJB2PTPN1CDC25B | |
| SCHEMBL20306742 | 0.87 | NT5E (0.51) | NT5ETSHRTACR2PTPN1CDC25B | |
| SCHEMBL14218242 | 0.86 | NT5E (0.48) | NT5ETSHRTACR2GJB2LMNA | |
| SCHEMBL12532834 | 0.86 | NT5E (0.48) | NT5ETSHRTACR2GJB2LMNA | |
| SCHEMBL20229514 | 0.86 | TSHR (0.53) | NT5ETSHRTACR2SELPLMNA | |
| SCHEMBL18392677 | 0.85 | TSHR (0.47) | NT5ETSHRTACR2LMNAKMT2A | |
| SCHEMBL19184870 | 0.84 | NT5E (0.51) | NT5ETACR2GJB2SELPLMNA | |
| SCHEMBL22677739 | 0.83 | TACR2 (0.46) | NT5ETSHRTACR2GJB2SELP | |
| SCHEMBL8992030 | 0.83 | NT5E (0.59) | NT5ETSHRLMNAPTPN1CDC25B | |
| SCHEMBL22073055 | 0.83 | TSHR (0.50) | NT5ETSHRTACR2LMNAPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3110825-B1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD (IN) | 2020-12-09 | — | — | EP | disclosed |
| US-10183962-B2 | Synthetic oligomers of Neisseria meningitis serogroup X and process of preparing them | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT. LTD. (IN) | 2019-01-22 | — | — | US | disclosed |
| US-20170066794-A1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT. LTD. (IN) | 2017-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170066794-A1 | NOVEL SYNTHETIC OLIGOMERS OF NEISSERIA MENINGITIS SEROGROUP X AND PROCESS OF PREPARING THEM | MLEC, MEN1, MAN2B2 | NT5E 1458/4885TSHR 4302/4885TACR2 3521/4885 |
| US-10183962-B2 | Synthetic oligomers of Neisseria meningitis serogroup X and process of preparing them | MLEC, MEN1, MAN2B2 | NT5E 1421/4885TSHR 4300/4885TACR2 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.